Miriam Weber Miller is Vice President of Investor Relations and Corporate Communications at Aptevo Therapeutics. She leads investor engagement and enterprise communications across investors, employees, partners, media, and the Board of Directors, shaping corporate narrative and market positioning.

Miriam brings more than 20 years of experience in investor relations, public relations, and corporate communications within healthcare. She has worked with early-stage biotech and publicly traded pharmaceutical organizations, with deep expertise in investor strategy, clinical data positioning, and corporate storytelling in high-visibility environments. Prior to Aptevo, she held senior leadership positions at Tiberend Strategic Advisors and Finn Partners and helped build the life sciences communications practice at Porter Novelli, leading programs around IPOs and strategic transactions and managing high-performing teams. Miriam holds a M.B.A. (Finance) from Fordham University and a B.A. (Journalism) from Rowan University.